HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

Opinion: Europe remains a problem for Ramsay

Yesterday’s stock price fall for Ramsay Health Care was not entirely unexpected. Shares in Australia’s largest private hospital operator dropped 5.75% to A$63.90 (US$49.81) after it revealed distinctly unimpressive first half figures.

Profits were down 3.7% to A$246.5 million.

Managing director Craig McNally admitted “ongoing challenges in the operating environment in Europe”. He wasn’t wrong and nor is the outlook expected to get better any time soon.

At the heart of the problem is Ramsay Générale de Santé, its French business, acquired in October 2014. Revenues fell 1.1% to €1.1 billion (US$1.35 billion) and EBITDAR was down 5.8% to €194.1 million.

“We are focused on achieving efficiencies in these businesses and, to this end, we are investing in a major transformation project in our French operations that will centralise non-core hospital resources and distinguish this business for the long term,” he said. Non-core hospital functions such as finance, administration and HR, will be relocated to a separate shared service centre in the outer suburbs of Paris

All good news, but this is not going to start until the second half and is going to take three years. A sign of how disruptive this is going to be is that Ramsay has provided for a restructuring charge of €43.7 million.

Although its presence is smaller, business is not much better in the UK. British revenues fell 4.8% to £206.2 million (US$286.7 million) with EBITDAR down 4.6% to £49.4 million thanks to NHS management demand strategies.

The issue for investors is that there are no discernable upsides in the short term. Pollyannas could point to Australian revenues. Domestic turnover was indeed up 4.3% to A$2.5 billion with a pleasing 9.1% jump in corresponding EBIT, but proposed caps on health insurance premia from the opposition Labor party could soon bring that growth to a shuddering halt.

Demographic trends and an aging population still support the Ramsay business case, but the next couple of years are going to be anything other than easy.

Posted on: 01/03/2018 UTC+08:00


Shares in orthopaedic specialists Asian Healthcare Specialists (AHS) shot up 52% at the open on their Catalist debut today.
Private equity firm Permira’s A$690 million (US$536 million) five-year leveraged buyout loan to help it acquire EQT’s stake in I-MED Radiology Network, Australia’s largest radiology company, has been flexed down.
Joanne Hannah has resigned as chief executive of Total Face Group, the first medical aesthetics company to list on the ASX, effective 1 May.
Lianluo Smart, which develops medical devices and wearable sleep respiratory products, has signed a strategic cooperation agreement with Meinian Onehealth Healthcare, the second largest healthcare provider in China.
After a choppy day of trading that saw shares in HKE Holdings, a Singapore-based contractor specialising in the medical and healthcare sectors, rise as much as 10%, they closed up 1.82% on their debut yesterday.
Summerset Group, New Zealand’s third-largest listed retirement village operator, has purchased land to build a retirement village in the suburb of Te Awa. The 9-ha property will be Summerset’s fourth in Hawke’s Bay. It already has villages in Havelock North, Hastings and Taradale.
Metlifecare, New Zealand’s second-largest listed retirement village operator, has said that its purchase of a 5.3 hectare waterfront site at Orion Point in Hobsonville, West Auckland, is now unconditional. The deal was announced at the end of October last year.
Hong Kong care home operator Pine Care Group has signed a management agreement with Zhejiang Yada Real Estate to operate and manage the Wuzhen Graceland Day Care Centre in Wuzhen, Zhejiang. Financial terms have not been disclosed.


In Vietnam, population and GDP growth have encouraged the country to think beyond technology in providing more health for more people.
Focused initiatives drive down medical inflation by more than 50 percentage points, according to a new report from Aon Asia Healthcare.
The Japanese healthcare system is a shining example of strength and resilience. At an average lifespan of 84 years, the Japanese society is not only the healthiest but also the "oldest" in the world. However, the challenges presented by an ageing population pose serious threats to the sustainability of the Japanese health system.
Susann Roth, senior social development specialist, Asian Development Bank, explains how investing in energy makes people healthier.
CFO Luke Chen’s reticence on the Q3 earnings call on Friday now makes sense. Jack Ma’s Yunfeng Capital and Alibaba Investment will buy out iKang Healthcare Group, China’s largest private preventive healthcare services provider, for around US$1.4 billion.
Following news that Malaysian sovereign wealth fund Khazanah Nasional will acquire Prince Court Medical Centre (PCMC) from Petronas, IHH Healthcare, Asia’s largest healthcare company, has signed an agreement with Khazanah to look after the day-to-day running of the medical centre.
Malaysian-based primary healthcare provider Qualitas Medical Group is due to push the button on its S$150 million (US$114 million) IPO in Singapore next week. It will be the first mainboard healthcare listing since IHH Healthcare floated in Kuala Lumpur and Singapore in July 2012.
Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, and Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, look at the four themes that are going to dominate healthcare this year.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices